Cresset Asset Management LLC bought a new stake in Bain Capital Specialty Finance, Inc. (NYSE:BCSF - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 1,391,514 shares of the company's stock, valued at approximately $25,006,000. Cresset Asset Management LLC owned 2.16% of Bain Capital Specialty Finance at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in BCSF. Cetera Investment Advisers acquired a new position in shares of Bain Capital Specialty Finance during the fourth quarter valued at $5,560,000. Bank of America Corp DE increased its stake in Bain Capital Specialty Finance by 3.0% during the 4th quarter. Bank of America Corp DE now owns 4,539,555 shares of the company's stock valued at $79,533,000 after buying an additional 133,753 shares during the period. Ameriprise Financial Inc. raised its position in shares of Bain Capital Specialty Finance by 21.3% during the 4th quarter. Ameriprise Financial Inc. now owns 142,632 shares of the company's stock worth $2,499,000 after buying an additional 25,017 shares in the last quarter. Comerica Bank lifted its stake in shares of Bain Capital Specialty Finance by 8.2% in the 4th quarter. Comerica Bank now owns 17,029 shares of the company's stock worth $298,000 after acquiring an additional 1,292 shares during the period. Finally, Northern Trust Corp boosted its holdings in shares of Bain Capital Specialty Finance by 16.5% in the fourth quarter. Northern Trust Corp now owns 43,204 shares of the company's stock valued at $757,000 after acquiring an additional 6,106 shares in the last quarter.
Bain Capital Specialty Finance Stock Performance
Shares of BCSF opened at $15.25 on Tuesday. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.41 and a quick ratio of 1.41. The firm's 50 day moving average is $16.01 and its 200-day moving average is $16.90. Bain Capital Specialty Finance, Inc. has a 12-month low of $13.20 and a 12-month high of $19.21. The stock has a market capitalization of $989.25 million, a P/E ratio of 7.66 and a beta of 0.82.
Bain Capital Specialty Finance (NYSE:BCSF - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.03. Bain Capital Specialty Finance had a net margin of 43.62% and a return on equity of 11.90%. The firm had revenue of $73.30 million for the quarter, compared to analyst estimates of $67.50 million. Equities research analysts anticipate that Bain Capital Specialty Finance, Inc. will post 2.06 EPS for the current fiscal year.
Bain Capital Specialty Finance Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Tuesday, December 16th will be issued a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.79%. The ex-dividend date of this dividend is Tuesday, December 16th. Bain Capital Specialty Finance's dividend payout ratio is 90.81%.
Insider Activity at Bain Capital Specialty Finance
In other news, Director Clare Stack Richer purchased 1,530 shares of Bain Capital Specialty Finance stock in a transaction that occurred on Monday, March 17th. The stock was acquired at an average price of $16.43 per share, for a total transaction of $25,137.90. Following the transaction, the director now owns 20,835 shares in the company, valued at $342,319.05. The trade was a 7.93 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.59% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
BCSF has been the subject of a number of research analyst reports. Wells Fargo & Company cut their target price on Bain Capital Specialty Finance from $19.00 to $16.00 and set an "overweight" rating for the company in a research report on Monday, April 28th. Keefe, Bruyette & Woods cut their price objective on Bain Capital Specialty Finance from $18.00 to $17.00 and set a "market perform" rating for the company in a report on Tuesday, April 8th.
Check Out Our Latest Stock Analysis on BCSF
About Bain Capital Specialty Finance
(
Free Report)
Bain Capital Specialty Finance, Inc is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bain Capital Specialty Finance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bain Capital Specialty Finance wasn't on the list.
While Bain Capital Specialty Finance currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.